Insulin effects on blood flow

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 2, 1999, Pages 135-140

  Steinberg, Helmut O ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; MICRODIALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSITRON EMISSION TOMOGRAPHY; SKELETAL MUSCLE; SYNDROME X; TISSUE BLOOD FLOW; VASODILATATION;

EID: 0033008885     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199904000-00009     Document Type: Article

References (43)

1. 1 Laakso M, Edelman SV, Brechtel G, Baron AD: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men. J Clin Invest 1990, 85:1844-52.
2. 2 Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J Clin Invest 1994, 94:1172-79.
3. 3 Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994, 94:2511-15.
4. 4 Chen YL, Messina EJ: Dilation of isolated skeletal muscle arterioles by insulin is endothelium dependent and nitric oxide mediated. Am J Physiol 1996, 270:H2120-H2124.
5. 5 Zeng G, Quon MJ: Insulin stimulated production of nitric oxide is inhibited by Wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996, 98:894-8. These investigators showed that insulin directly stimulates nitric oxide release in cultured endothelial cells and that this effect involves the classic insulin cell signaling pathways.
6. 6 Bertuglia S, Colantuoni A: Insulin-induced arteriolar dilation after tyrosine kinase and nitric oxide synthase inhibition in hamster cheek pouch microcirculation. J Vasc Res 1998, 35:250-6.
7. 7 Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, Shionoiri F, Yahagi N, Kadowaki T, Tamemoto H, Ishibashi S, Yazaki Y, Makuuchi M: Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 1998, 101:1784-8.
8. 8 Lembo G, laccarino G, Vecchione C, Barbato E, Izzo R, Fontana D, Trimarco B: Insulin modulation of an endothelial nitric oxide component present in the alpha-2 and beta adrenergic responses in human forearm. J Clin Invest 1997, 100:2007-2014.
9. 9 Touyz RM, Tolloczko B, Schiffrin EL: Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension 1994, 23:125-8.
10. 10 Folli FC, Kahn R, Hansen H, Bouchie JL, Feener EP: Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 1997, 100:2158-69.
11. 11 Petrie JR, Ueda S, Morris AD, Murray LS, Elliott HL, Connell JMC: How reproducible is bilateral forearm plethysmography? Br J Clin Pharm 1998, 45:131-9. The authors characterize the limitations of plethysmography to measure forearm blood flow.
12. 12 Doenst T, Taegtmeyer H. Profound underestimation of glucose uptake by [18F]2-deoxy-2-fluoroglucose in reperfused rat heart muscle. Circulation 1998, 97:2454-2462.
13. 13 Nuutila P, Raitakari M, Laine H, Kirvela O, Takala T, et al.: Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest 1996, 97:1741-47.
14. 14 Scherrer U, Sartorio C: Insulin as a vascular and sympathoexcitory hormone: Implications for blood pressure regulation, insulin sensitivity, and cardiovascular mortality. Circulation 1997, 96:4104-4113.
15. 15 Baron ADG, Johnson A, Cronin J, Learning R: Effect of perfusion rate on the time course of insulin mediated skeletal muscle glucose uptake. Am J Physiol 1996, 271:E1067-E1072.
16. 16 Laine H, Knuuti MJ, Ruotsalainen U, Raitakari M, Iida H, Kapanen J, Kirvela O, Haaparanta M, Yki-Jarvinen H, Nuutila P: Insulin resistance in essential hypertension is characterized by impaired insulin stimulation of blood flow in skeletal muscle. J Hypertension 1998, 16:211-19.
17. 17 Raitakari MP, Knuuti J, Raitakari OT, Laine H, Ruotsalainen U, Kirvela O, et al.: Effects of insulin on blood flow and volume in skeletal muscle of patients with IDDM: studies using [15O]H2O, [15O]CO, and positron emission tomography. Diabetes 1997, 46:2017-21.
18. 18 Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD: Obesity/Insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996, 97:2601-2610.
19. 19 Baron AD, Brechtel-Hook G, Johnson A, Hardin D: Skeletal muscle blood flow - a possible link between insulin resistance and blood pressure. Hypertension 1993, 21:129-135.
20. 20 Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, Haaparanta M, Knuuti J, Nuutila P: Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 1998, 101:1156-62.
21. 21 Panza JA, Quyyumi A, Brush JE, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990, 323:22-7.
22. 22 Forte PM, Smith LM, Milne E, Sutherland J, Benjamin N: Basal nitric oxide synthesis in essential hypertension. Lancet 1997, 349:837-42. Sophisticated application of tracer technology demonstrated decreased total body production of nitric oxide in hypertensive subjects.
23. 23 Paradisi G, Steinberg HO, Shepard M, Baron AD: Polycystic syndrome is associated with endothelial dysfunction. Diabetes 1998, 47:1 197.
24. 24 Steinberg HO, Cressman E, Wu Y, Hook G, Cronin J, Johnson A, Baron AD: Insulin mediated nitric oxide production is impaired in insulin resistance. Diabetes 1997, 46:24A.
25. 25 Avogaro A, Piarulli F, Valerio A, Miola M, Calveri M, Pavan P, et al.: Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 1997, 46:1040-46.
26. 26 Bonadonna R, Saccomani MP, Del Prato S, Bonora E, DeFronzo RA, Cobelli C: Role of tissue specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation 1998, 98:234-241.
27. 27 Raitakari M, Knuuti MJ, Ruotsalainen U, Laine H, Makela P, Teras M, Sipila H, et al.: Insulin increases blood volume in human skeletal muscle: studies using [15O]CO and positron emission tomography. Am J Physiol 1995, 269:E1000-E1005.
28. 28 Laine H, Knuuti MJ, Ruotsalainen U, Utrianinen T, Oikonen V, Raitakari M, Luotolahti M, Kirvela O, Vicini P, Cobelli C, Nuutila P, Yki-Jarvinen H. Preserved relative dispersion but blunted stimulation of mean flow, absolute dispersion, and blood volume by insulin in skeletal muscle of patients with essential hypertension. Circulation 1998, 97:2146-53.
29. 29 Rattigan S, Clark MG, Barrett EJ: Hemodynamic actions of insulin in rat skeletal muscle. Evidence for capillary recruitment. Diabetes 1997, 46:1381-88.
30. 30 Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997, 100:1230-39. Two hour elevation of free fatty acids causes impairment in leg blood flow responses to graded intrafemoral artery infusions of the endothelium-dependent vasodilator methacholine chloride but not to the endothelium-independent vasodilator sodium nitroprusside.
31. 31 Lundman P, Erickson M, Cchenck-Gustavson K, Karpe K, Tornvall P: Transient trigyleridemia decreases vascular reactivity in young, healthy mean without factors for coronary heart disease. Circulation 1997, 96:3266-3268.
32. 32 Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockcroft JR, Brett SE, Ritter JM: Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am Coll Cardiol 1997, 29:964-8.
33. 33 Steinberg HO, Cronin J, Hook G, Baron AD: Elevation of free fatty acids impairs insulin mediated vasodilation and nitric oxide production. Diabetes 1998, 47:0252.
34. 34 Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 1995, 26:764-70.
35. 35 Niu X, Liu LY, Hu ML, Chen X: Some similarities in vascular effects of oleic acid and oxidized low-density lipoproteins on rabbit aorta. J Mol Cell Cardiol 1995, 27:531-9.
36. 36 Lu G, Greene EL, Nagai N, Egan BM. Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells [In Process Citation]. Hypertension 1998, 32:1003-10.
37. 37 Piatti P, Monti LD, Conti M, Baruffaldi L, Galli L, Phan CV, Guazzini B, Pontiroli AE, Pozza G: Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 1996, 45:316-21.
38. 38 Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A, De Mattia G: Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 1997, 105:38-40.
39. 39 Ahlborg G, Lundberg JM: Nitric oxide-endothelin-1 interaction in humans. J Appl Physiol 1997, 82:1593-600.
40. 40 Nolan J, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1998, 331:1188-93.
41. 41 Fujishima S, Ohya Y, Nakamura Y, Onaka U, Abe I, Fujishima M: Troglitazone, an insulin sensitizer, increases forearm blood flow in humans. Am J Hypertens 1998, 11:1134-7.
42. 42 Tack CJJ, Ong MKE, Lutterman JA, Smits P: Insulin-induced vasodilation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 1998, 41:569-576.
43. 43 Laakso M, Edelman SV, Brechtel G, Baron AD: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992, 41:1076-1083.